Biolase stock

Should you buy BIOLASE (Biol) stock? If you're looking for high-growth stocks that still see plenty of opportunities on the horizon, consider BIOLASE (BIOL).

What did BIOLASE Inc announce?

BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo today announced the ■■■■■ development of EdgePRO, a next-generation laser-guided microfluidic irrigation device for endodontists.

What are analysts' target price targets for BIOLASE's stock?

3 analysts have set target prices for BIOLASES stocks for more than twelve months. Their predictions range from $ to $. On average, they expect BIOLASE stock to rise to $1 next year. This indicates a possible increase in the current price of the stock.

When will BIOLASE report its Q2 earnings?

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2021 and its revenue forecast for the third quarter of 2021. BIOLASE, Inc. will report the results for the second quarter of 2021 on August 12, 2021.

Onvo stock

Is the BIOLASE stock a buy or sell?

The Biolase stock also has a sell signal of a short-term moving average, but there is a buy signal of a long-term moving average. Since the short-term average is higher than the long-term average, there is a general buy signal for the stock that gives a positive outlook for the stock.

Where can I buy Biol shares?

BIOL shares can be purchased through any online brokerage account. Popular online brokers include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare the best brokers here.

Is the betabiolase stock a buying opportunity?

Biolase finds support at the cumulative volume at the USD level, and this level could be a buying opportunity as a bullish reaction can be expected if the support is tested. This stock can move a lot during the day (volatility), and with a low periodic trading volume, this stock is considered risky.

What is the earnings statement for BIOLASE (Biol)?

BIOLASE, Inc. (NASDAQ: BIOL) released its quarterly results on Wednesday, Aug. 11. The medical technology company reported earnings per share (EPS) for the quarter ($), surpassing the Sachs consensus ($).

Smiledirectclub stock

Does BIOLASE have a board of directors?

BIOLASE, Inc. (NASDAQ: BIOL), the world's largest supplier of dental lasers, today announced the appointment of three new members to its board of directors. Board of Directors) with immediate effect.

How many BIOLASE laser systems have been sold?

BIOLASE has sold more than 41,200 laser systems in more than 80 countries around the world. The laser products under development are aimed at the primary dental market for BIOLAZ and other related consumer and medical applications.

What did biolase inc announce 2018

IRVINE, CA Nov 1, 2018 /PRNewswire/BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today, Monday, November 12, 2018, announced its financial and operating results for the third quarter of 2018, known for the opening of financial markets.

What did biolase inc announce 2020

IRWIN, CA June 8, 2020 /PRNewswire/BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today canceled its securities purchase agreement with institutional investors to purchase approximately its common stock via listing. Nasdaq Rules and Warrants on Shares in a Parallel Private Placement.

What did biolase inc announce last

IRWIN, CA July 16, 2020 /PRNewswire/BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the company's oversubscription is expiring.

When did BIOLASE announce the 1-5 reverse split?

The merger of 15 shares was announced on Thursday 10 May 2018. The number of shares held by shareholders was adjusted after the last call on Thursday 10 May 2018. The investor who owned 100 shares of BIOLASE before the merger will receive 20 shares after the split.

Is BIOLASE stock a buy or sell?

There are currently 3 stock purchase valuations. Wall Street analysts agree that investors should buy BIOLASE stock. Check out BIOLASE analyst ratings or explore the top-rated stocks. What is MarketBeat's preference for BIOLASE?

When is BIOLASE's next quarterly earnings announcement?

BIOLASE is expected to release its next quarterly results on Thursday, November 11, 2021. View BIOLASE's earnings forecast. What was BIOLASES profit in the last quarter? BIOLASE, Inc. (NASDAQ: BIOL) released its quarterly results on Wednesday, Aug.

How has covid-19 affected BIOLASE's stock?

According to the World Health Organization (WHO), shares of BIOLASE traded in the dollar on March 11, 2020, when COVID19 (coronavirus) reached pandemic status. Since then, BIOL's shares have risen and are now trading at USD. See which stocks have been most affected by COVID19.

Are there any forward-looking statements in the BIOLASE press release?

BIOLASE, Waterlase and Waterlase iPlus are registered trademarks of BIOLASE, Inc. This press release contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995 that involve significant risks and uncertainties, including statements about results. the fourth trimester.

What does BIOLASE do?

BIOLASE is a medical technology company that develops, manufactures, markets and markets laser systems for dentistry and medicine. BIOLASES products promote the practice of dentistry and medicine for patients and health professionals.

Why choose BIOLASE laser dentistry?

BIOLASES' innovative products offer advanced technology at competitive prices to deliver outstanding results to dentists and patients. BIOLASES' main products are revolutionary dental laser systems that allow you to perform a wide variety of dental procedures, including complex and cosmetic surgical procedures.

What did biolase inc announce 2019

Irvine, CA Dec. 9, 2019 /PRNewswire/BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced the launch of its new Epic Hygiene Laser at the New York City Dental Meeting in New York, York. Nov 29 - Dec 4. The laser is officially approved by the Food and Drug Administration (FDA).

Does BIOLASE (BIOLASE) have a negative return on equity?

The medical technology company reported earnings per share (EPS) for the quarter ($), which beat the Sachs consensus ($) on $BIOLASE. BIOLASE had a negative return on equity and a negative net margin for the year compared to last year.

What are analysts' target price targets for biolase' s stock results

What is the consensus assessment and purpose of the BIOLASES course? Based on 3 analyst ratings from the past year, the consensus rating for Buy BIOLASE is based on the current ratings of Buy 3 for BIOL. The 12-month average price target for BIOLASE is $ with a high $ target and a low $ target.

What is the upside for BIOLASE's stock?

On average, they expect BIOLASE's stock price to hit the US dollar next year. This indicates a possible increase in the current price of the stock. Check out analyst target prices for BIOLASE or top-rated Wall Street stocks.

What is BIOLASE's guidance for Q3?

On Thursday (September 2), BIOLASE released its updated earnings forecast for the third quarter of 2021. The company disclosed its earnings per share (EPS) for the period. The company has released a multimillion-dollar sales forecast, compared to the consensus estimate of millions of dollars in sales. What is the target price for BIOL?

What are analysts' target price targets for biolase' s stock list

Based on 3 analyst ratings from the past year, the consensus rating for Buy BIOLASE is based on current ratings of Buy 3 for BIOL. The 12-month average price target for BIOLASE is $ with a high target $ and a low target $ Learn more.

What are analysts' target price targets for biolase' s stock chart

The 12-month average price target for BIOLASE is $ with a high $ target and a low $ target. Read More Do Wall Street Analysts Love BIOLASE More Than Its Competitors?

What do analysts expect for BIOLASE's stock's price?

2 analysts of the stock market research have set an annual target price for the BIOLASE shares. Their predictions range from $ to $. On average, they expect BIOLASE stocks to rise to USD$ in the next 12 months. This indicates a possible increase in the current price of the stock.

When did bibiolase announce its stock reverse split?

The stock merger of BIOLASES before the close of business on Friday, May 11, 2018 The merger of 15 shares was announced on Thursday, May 10, 2018. The number of shares held by shareholders was adjusted after the closing of operations on Thursday, May 10.

What is BIOLASE technology?

Biolase Technology (BIOL) Start with Biolase Technology, a leading developer, manufacturer and innovator in dental laser technology. Lasers offer many benefits to dentists and their patients, including fewer sprays and a smoother feel during treatment and more comfortable healing afterwards.

Is Opgen (OPG) stock a buy or sell?

OpGen received a buying consensus rating. The average business rating is based on 2 purchase ratings, no retention rating, and sales ratings. Increase / decrease target price. Analyst consensus forecast, OpGen price is expected to rise from current $.

How many shares are in Opgen stock after the reverse split?

The number of shares held by shareholders was adjusted after market close on Thursday, January 18, 2018. An investor who owned 100 OpGen shares before the split will have 4 shares after the split. What is OPGN's target price?

What is opopgen Inc?

OpGen Inc is a precision medicine company that uses the power of molecular diagnostics and computation to fight infectious diseases.

When is Opgen's next quarterly earnings announcement?

OpGen is expected to release its next quarterly report on Wednesday, November 10, 2021. View OpGen's earnings forecast. What was OpGens profit in the last quarter? OpGen, Inc. (NASDAQ: OPGN) released its quarterly results on Thursday, August 12.

How does forecast BIOLASE stock forecast work?

Forecast The forecast for Biolase reserves is based on your current time horizon. Investors can use this forecasting interface to forecast historical Biolase stock prices and determine the direction of future Biolase trends based on several well-known forecasting models. However, it is generally wrong to only look at historical price movements.

Will Biol stock price drop / Fall / Rise / Fall?

Shares of Biolase trade today in US dollars. Will the BIOL share price fall / fall? Yes. The price of Biolaza shares can fall from one dollar to another. The change is %. Will the price of BIOL stock rise / rise / rise?

What is the stock price for acasti Pharma (ACST)?

The stock price of Acasti Pharma (NASDAQ:ACST) is $ as of the last update on Wednesday, 20:00:03 GMT+0000 (UTC). Does Acasti Pharma (ACST) Pay Dividends?

Who bought acacst stock?

During the last quarter, ACST shares were acquired by several institutional investors, including Renaissance Technologies LLC, Citadel Advisors LLC and Quadratnye Operations LLC. Check out Acasti Pharma's insider buy and sell offers or check out the best insider buy deals. How do I buy Acasti Pharma shares?

How has coronavirus affected acasti pharma's stock?

According to the World Health Organization (WHO), Acasti Pharmas traded for $11 on March 11, 2020, when the coronavirus reached pandemic status. Since then, ACST shares have fallen and are now at $.

What does the 1-8 reverse split mean for acasti pharma stock?

The combination of 18 shares was announced on Tuesday, August 31, 2021. The number of shares held by shareholders was adjusted after close of business on Tuesday, August 31, 2021. The investor who owned 100 shares of Acasti Pharma prior to the consolidation will split received 13 shares.

What was orbit international's net income for the three months ended March 2021?

Mitchell Binder, President and CEO of Orbit International Corp. said, "His net income for the quarter ended March 31, 2021 was $1,827,000, compared to $20,000 in the comparable prior period.

What does orbit International do?

Orbit International Corp. develops and supplies hardware and software solutions. It operates in the Electronics Group and Power Group segments. The Electronics Group segment develops and produces electronic components and subsystems.

Why did the sales of the orbit power group decrease?

This revenue decline is due to lower sales of the Orbit Power Group (“OPG”) due to lower shipments from CATS and lower shipments from its business unit. The shipment of CATES units during the current period was negotiated by OPG in a contract in September 2017.

How much money does BIOLASE (BIOLASE) make a year?

BIOLASE has a market cap of millions of dollars and annual sales of millions. The medical technology company has annual net income (earnings) or ($) of $16,830 based on earnings per share.

Where can I buy NGAC shares?

NGAC shares can be purchased through any online brokerage account. Popular online brokers include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare the best brokers here.

Is ngngac stock up 30% on Monday?

NGAC stock rose Monday afternoon. At the time of publication, William White had no position (direct or indirect) on the securities referred to in this article.

Will nextnextgen acquisition (NGAC) take Xos Trucks public?

NextGen Acquisition (NASDAQ: NGAC) rebounded Monday amid rumors that Special Purpose Acquisition Company (SPAC) is considering a merger with Xos Trucks. Here's everything investors need to know about SPAC's merger negotiations and the two companies behind it.

What is NextGen acquisition's (NxGn) stock price potential upside?

Their forecasts range from $ to $, on average they expect NextGen's acquisitions to reach $ in the next 12 months. This indicates a possible increase in the current value of the shares.